Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief: GMPs for finished pharmaceuticals

This article was originally published in The Tan Sheet

Executive Summary

GMPs for finished pharmaceuticals: FDA extends until Sept. 30 the deadline for comment on a proposed rule published May 3 that would clarify certain manufacturing, quality control and documentation requirements for current Good Manufacturing Practices for finished forms of pharmaceuticals, the agency announces in the July 29 Federal Register. FDA granted the extension in response to a request from the Nonprescription Drug Manufacturers Association...





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts